Medical network - on March 17, the ministry of human resources and social security has formally announced the national basic medical insurance, inductrial injury insurance and maternity insurance drug catalogue (2017 edition) "(hereinafter referred to as the catalog of health care). This edition is health care medicine directory, new varieties, 91 children's drugs, clear are suitable for children's medicines or dosage forms to about 540. The personage inside course of study thinks, which will further strengthen the protection of children's drugs, as well as related to children's pharmaceutical companies to open a new round of industry development space.
Catalogue of the new health care 91 kinds of children's drugs
Dyne He Shuwang pharmaceutical r&d center general manager of the economic information daily, reporters that can be seen from the 2017 version of the medical insurance directory to increase children's medicine, health care is to encourage innovation, but also shows the improvement of national importance to children's drugs. After entering the health care, "more children's drugs can relieve the economic burden for patients. On the other hand, into the medical insurance directory of all medicines after the screening, played a significant role in drug safety for children also.
Although this increases the pharmaceutical enterprise emphasis on children's drugs, but it is worth noting that at present Chinese medicine formulations for children is still abnormal shortage in the market. , according to data provided by the chamber of commerce for pharmaceutical industry, China has more than 3500 varieties, children's only 60 kinds, proportion was only 1.7%, children's types, special specifications, special taste a severe shortage of drugs. From 2011 to 2013, Beijing medical university of Beijing children's hospital affiliated to a present situation of domestic children's drugs, according to a survey in 15 medical institutions for children with 6020 drugs, only 45 children decongestion. Administration of state food and drug supervision and administration of a statistics show that 90% of the country's drug without children's formulations. The so-called children's medicine, more just the decrement of adult medicine.
The personage inside course of study is generally believed that children's medicine into the health care under the superposition of all kinds of good policy, to further stimulate children's medicine market development, children's medicine market will be a piece of blue ocean. Studies have reported that on January 1, 2016 the implementation of the "two children" policy, every year from 1 million to 2 million newborns, neonatal number is expected to more than 20 million, 2018, that number will directly stimulate children's medicine market demand sharply.
Children's medicine development boards are lacking
At present our country children's medicine, it is necessary to break the development there are still some obstacles in research and development, for example, children's medicine has not yet differs from adult drug research and development, it is short for the part of the enterprise.
"At present, the children's drugs' eat by snapping, quantity by guess" phenomenon still exists." He Shuwang said, children are not adults, as a special medication group has its own unique physiological characteristics of children in different period of drug absorption, distribution, metabolism and excretion ability is different, the high incidence of adverse reactions than adults use, therefore the indicators of children's medicine is higher than adult medicine demands more rigorous, dosage form. In addition, the clinical data, taste special adjustment, etc are to increase the enterprise research and development costs.
Children to solve drug shortage situation, must further improve the r&d and production of pharmaceutical companies. Drug research and development institutions and pharmaceutical production enterprise r&d department should be aimed at high incidence of disease on drug research and development. He Shuwang tells a reporter, dyne pharmaceutical r&d not less than 5% of the annual sales income, the amount of nearly 70 million, 2016, 2017 r&d budget will be more than one.
"As for the children's drugs, dyne r&d investment is relatively high." According to He Shuwang, in recent years, dyne increased r&d investment, carried out extensive cooperation with universities, research institutes, "according to the characteristics of children's drugs, we have developed some of the core technology, set up advanced technology platform, dosage form covers oral liquid, drops, granules, dry suspension agent, orally disintegrating tablets, transdermal patches, furthermore, lungs, children are the most appropriate formulations including topical ointment. Later we will be a common disease and frequently encountered disease for children intensify research and development, covering both children's rare disease treatment, and do some on the corresponding drug dosage forms and improvement on the palate." He Shuwang said.
The dyne pharmaceutical products in the research of children's drugs is about more than 40. Has listed the star products of the "new" (vitamin AD drops), "cover" flute hin (compound calcium carbonate effervescent granules) by the industry, experts and market recognition. In 2016, the new successively won the domestic many from the pharmaceutical industry, sales terminals and maternal and infant industry.
Drug firms to tailor medicine in children
In recent years, the state has increased the attention and input to the child decongestion, medicine application review and research and development for children provide good New Deal. Dyne pharmaceutical group President, said Yang jie children pharmaceutical industry should establish a "made-to-measure" concept, in the perspective of children discover problems, analyze and solve problems, with professional r&d, design, production supervision to protect the safety of the children's drugs.
Dyne pharmaceutical industry has always been to "make the thousands of Chinese children's health" as own duty, and with the aim to practice "tailor medicines for children". Yang jie, according to the research concept of medicine for children in accordance with the customized company determines the clear development ideas: first, in view of the domestic listed drugs to improve taste, enrich the research work of dosage form, complete specifications; Foreign drug localization work; Original innovation work, to develop with independent intellectual property rights the research of medicines for children.
Yang jie said, facing the problems in the field of national children's medicine, as a pharmaceutical company, can't escape, it is imperative to figure out what breed is the shortage of children, children must be the same composition for different ages of different dosage forms, specifications and flavors of pharmaceutical research, improve the clinical data of children. "Drug quality inspection does not come out, also is not produced, is given by the design. Quality is the result of design, tailor, only children to ensure medication safety." Yang jie said. |
